Has Amie Bevis received payments from drug or device companies?

Yes. Drug and device makers reported $1,902 in general payments to Amie Bevis across 93 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Amie Bevis did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Amie Bevis come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Amie Bevis

Nurse Practitioner · Tyler, TXNPI 1225765795

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Corium, LLC at 25.0% of the total.

$1,902in general payments, 2019–2025

Across 93 payments — averaging $20.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Corium, LLC$475
Pfizer$215
Exact Sciences$182
AbbVie$160
Supernus Pharmaceuticals, Inc.$143
Genentech USA, Inc.$112
plus $615 from 18 others

What the payments were for

Food & beverage$1,902100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Corium, LLC	31	$475
Pfizer	5	$215
Exact Sciences	11	$182
AbbVie	9	$160
Supernus Pharmaceuticals, Inc.	2	$143
Genentech USA, Inc.	1	$112
Sanofi-aventis U.S. LLC	2	$107
Bayer	5	$75
Novo Nordisk	4	$67
Lilly USA, LLC	4	$59
Scilex Pharmaceuticals Inc.	2	$43
Ironshore Pharmaceuticals Inc.	3	$41
Regeneron Healthcare Solutions, Inc.	1	$28
Nevro Corp.	2	$28
Kowa Pharmaceuticals America, Inc.	1	$21
Phathom Pharmaceuticals, Inc.	2	$20
Boehringer Ingelheim	1	$20
Mylan Specialty L.p.	1	$20
Biohaven Pharmaceutical Holding Company Ltd.	1	$20
Johnson & Johnson	1	$14
Inspire Medical Systems, Inc.	1	$13
Dynavax Technologies Corporation	1	$13
GSK	1	$13
Idorsia Pharmaceuticals US Inc	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,902 in reported general payments places this provider in the 85th percentile of 5,422 nurse practitioner providers in Texas.

See all nurse practitioner providers in Texas →

Other nurse practitioner in Tyler

Roger ChapmanTyler$211K
David McCaskillTyler$27K
Cecilia DavisAustin$262K
Melanie MorrisHouston$254K
Stephanie BrownHarlingen$235K
Brittney MisercolaKilleen$223K
Corrie BerkSan Antonio$155K
Samantha OnealDallas$133K
Onna FeuchterSouthlake$108K
Stephanie AgrellaRound Rock$102K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →